Announce Date | 03/05/2025 |
EPS Normalized Actual | $-0.19 (Miss by $-0.05) |
EPS GAAP Actual | $-0.19 (Miss by $-0.05) |
Revenue Actual | $0.011867B |
Revenue Surprise | Beat by $11.867M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.095 |
EPS GAAP Estimate | $-0.095 |
Revenue Estimate | $0.0141B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 0.5 | 5.42 | 0.38572 | 0.63171 | 1 |
Dec 2028 | 0.66 | 4.11 | 0.61289 | 0.73738 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.19 | -0.1 | 0.011867B | -11.28% | -0.72M |
FQ3 2024 (Sep 2024) | -0.13 | -0.0375 | 0.013542B | 3.99% | 0.94M |
FQ2 2024 (Jun 2024) | 0 | -1.34259 | 0.020099B | 34.12% | -2.65M |
FQ1 2024 (Mar 2024) | -0.17 | -0.08125 | 0.012053B | 7.62% | -0.21M |
FQ4 2023 (Dec 2023) | -0.12 | -0.12 | 0.013206B | -174.25% | 13.21M |
FQ3 2023 (Sep 2023) | 0 | 0 | 0.013002B | 11.84% | 13M |
FQ2 2023 (Jun 2023) | -0.0001 | -0.0001 | 0.013241B | -0.18% | 13.24M |
FQ1 2023 (Mar 2023) | 0.0003 | 0.0003 | 0.011134B | 100% | 11.13M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
-0.095
Consensus Revenue Estimates
0.0141B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Sep 2026) | -0.083333 | -- | -0.09014892 | -0.07774828 | 1 |
FQ2 2026 (Jun 2026) | -0.1 | -- | -0.10818 | -0.09329831 | 1 |
FQ1 2026 (Mar 2026) | -0.10667 | -- | -0.11539 | -0.09952131 | 1 |
FQ4 2025 (Oct 2025) | -0.095 | -100 | -0.0990404 | -0.09076488 | 2 |
FQ3 2025 (Jul 2025) | -0.095 | -36.84 | -0.0990404 | -0.09076488 | 2 |
FQ2 2025 (Jun 2025) | -0.095 | -- | -0.09965391 | -0.09152182 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Sep 2026) | 0.02B | -- | 0.02B | 0.02B | 4 |
FQ2 2026 (Jun 2026) | 0.01B | -- | 0.01B | 0.01B | 4 |
FQ1 2026 (Mar 2026) | 0.01B | -- | 0.01B | 0.01B | 4 |
FQ4 2025 (Oct 2025) | 0.01B | 17.59 | 0.01B | 0.01B | 2 |
FQ3 2025 (Jul 2025) | 0.01B | 3.96 | 0.01B | 0.01B | 2 |
FQ2 2025 (Jun 2025) | 0.01B | -42.55 | 0.01B | 0.01B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
6
EPS # of in-lines
1
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.09 | -0.19 | -0.1 | 52.63% |
FQ3 2024 (Sep 2024) | -0.0925 | -0.13 | -0.0375 | 28.85% |
FQ2 2024 (Jun 2024) | 1.34259 | 0 | -1.34259 | -INF% |
FQ1 2024 (Mar 2024) | -0.08875 | -0.17 | -0.08125 | 47.79% |
FQ4 2023 (Dec 2023) | -0.12 | -0.12 | 100% | |
FQ3 2023 (Sep 2023) | 0 | 0 | NAN% | |
FQ2 2023 (Jun 2023) | -0.0001 | -0.0001 | 100% | |
FQ1 2023 (Mar 2023) | 0.0003 | 0.0003 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0.01B | $0.01B | $-0.72M | -6.05% |
FQ3 2024 (Sep 2024) | $0.01B | $0.01B | $0.94M | 6.91% |
FQ2 2024 (Jun 2024) | $0.02B | $0.02B | $-2.65M | -13.21% |
FQ1 2024 (Mar 2024) | $0.01B | $0.01B | $-0.21M | -1.73% |
FQ4 2023 (Dec 2023) | $0B | $0.01B | $13.21M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.01B | $13M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.01B | $13.24M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.01B | $11.13M | 100% |